Why the study?
Does beta-blocker therapy reduce all-cause mortality and recurrent MI in patients surviving at least 1 year after their first MI?
Population
865 patients discharged from hospitals after their first myocardial infarction between January 1994 and…
Comparison
Beta-blocker therapy vs No beta-blocker therapy (unexposed patients)
Design
Cohort
Authors
Loading...
Supports beta-blocker adherence counseling post-MI; leaves open whether benefits are causal or apply to all long-term survivors without RCTs.
Does beta-blocker therapy reduce all-cause mortality and recurrent MI in patients surviving at least 1 year after their first MI?
Good adherence to beta-blockers after a first MI is associated with significantly reduced mortality, yet high-risk patients who might benefit most are less likely to receive them.
Wei et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: